Browsing by Issue Date, starting with "2003-05"
Now showing 1 - 7 of 7
Results Per Page
Sort Options
- Combined Pancreas-Kidney Transplantation: A New Program in Portugal, Results From the First 12 CasesPublication . Martins, L.; Henriques, A.; Dias, L.; Ventura, A.; Seca, R.; Almeida, R.; Dores, J.; Bacelar, C.; Oliveira, F.; Lhamas, A.; Amil, M.; Rua, F.; Coelho, T.; Esteves, S.; Ribeiro, A.; Pereira, R.; Sarmento, A.; Teixeira, M.; Pereira, M.Transplant Proc. 2003 May;35(3):1107-8. Combined pancreas-kidney transplantation: a new program in Portugal, results from the first 12 cases. Martins L, Henriques A, Dias L, Ventura A, Seca R, Almeida R, Dores J, Bacelar C, Oliveira F, Lhamas A, Amil M, Rua F, Coelho T, Esteves S, Ribeiro A, Pereira R, Sarmento A, Teixeira M, Pereira M. Transplantation Department, Hospital Santo António, 4050, Porto, Portugal. lasalete@clix.pt PMID: 12947877 [PubMed - indexed for MEDLINE]
- "Very urgent" kidney transplantation: results from one center.Publication . Costa, S.; Ventura, A.; Costa, T.; Martins, L.; Henriques, A.; Sarmento, A.Transplant Proc. 2003 May;35(3):1066. "Very urgent" kidney transplantation: results from one center. Costa S, Ventura A, Costa T, Martins L, Henriques A, Sarmento A. Nephrology Department, Hospital de Santo António, 4050 Porto, Portugal. PMID: 12947858 [PubMed - indexed for MEDLINE]
- Homocysteine levels in pediatric renal transplant recipients.Publication . Mota, C.; Fonseca, Isabel; Santos, M.J.; Costa, T.; Faria, M.S.; Henriques, A.C.; Sarmento, A.M.; Pereira, E.; Pereira, M.Transplant Proc. 2003 May;35(3):1093-5. Homocysteine levels in pediatric renal transplant recipients. Mota C, Fonseca I, Santos MJ, Costa T, Faria MS, Henriques AC, Sarmento AM, Pereira E, Pereira M. Department of Paediatric Nephrology, Maria Pia Children's Hospital, R. da Boavista, 827, 4050-111, Porto, Portugal. ccmotacosta@hotmail.com PMID: 12947872 [PubMed - indexed for MEDLINE
- Portuguese‐type amyloidosis (transthyretin amyloidosis, ATTR V30M).Publication . Lobato, L.J Nephrol. 2003 May-Jun;16(3):438-42. Portuguese-type amyloidosis (transthyretin amyloidosis, ATTR V30M). Lobato L. SourceDepartment of Nephrology, Santo António General Hospital, Porto, Portugal. llobato@netcabo.pt Abstract Portuguese-type amyloidosis (transthyretin amyloidosis, ATTR V30M) is the most common form of systemic hereditary amyloidosis, inherited in autosomal dominant mode. The disease, also called familial amyloid polyneuropathy type I (FAP-I), is caused by a mutant transthyretin (TTR) protein, which is synthesized by the liver. A single amino acid substitution of methionine for valine at position 30 of the TTR molecule (TTR V30M) was found in Portuguese patients. The clinical disease usually manifests as a peripheral sensory, motor and autonomic neuropathy starting in the 3rd or 4th decade of life. Renal manifestations of ATTR V30M, like other amyloidoses, are different levels of proteinuria and renal insufficiency. In ATTR V30M a large amyloid deposition in the medullary zone of the kidney and tubules is characteristic. A more extensive glomerular and vascular involvement is present only in patients with renal manifestations. A prospective survey in the north of Portugal showed that a stage of microalbuminuria (MA) could precede nephropathy and neurological disease. Nephropathy in FAP-I is present in one-third of affected patients and tends to aggregate in families. The progression towards end-stage renal disease (ESRD) affects 10% of the patients, and the survival after initiation of dialysis is a mean of 21 months. Patients who progress to ESRD have a late onset of neuropathy and lower prevalence of clinical disease in their families. Liver transplantation is a widely accepted treatment for FAP-I, and combined liver-kidney transplantation is also an option for selected patients with FAP-I and ESRD.
- Ethics of cadaveric organ procurement and allocation (II).Publication . MICHAŁOWICZ, B.; K SZCZYGIEŁ, REV; SAFJAN, M; RZEPLIŃSKI, A; LAND, W; NORTON DE MATOS, A; B CHYROWICZ, SISTER; W BOŁOZ, REV; YUSSIM, A; WICHROWSKI, M.Transplant Proc. 2003 May;35(3):1219-20. Ethics of cadaveric organ procurement and allocation (II). Michałowicz B, Rev K Szczygieł, Safjan M, Rzepliński A, Land W, Norton de Matos A, Sister B Chyrowicz, Rev W Bołoz, Yussim A, Wichrowski M. PMID: 12947911 [PubMed - indexed for MEDLINE]
- Long-Term Complications After Renal TransplantationPublication . Martins, L.; Ventura, A.; Costa, S.; Henriques, A.; Dias, L.; Sarmento, A.IN the past, every effort was directed at the prevention of acute rejection in renal transplant (RT) patients (pts). Ever since the introduction of the new immunosuppressive agents in the late 1990s, the short-term results of renal graft survival are considered satisfactory. In recent years, the prevention of long-term graft loss and the extension of life expectancy have gained new emphasis. The immunosuppressive agents though, namely calcineurin-inhibitors and steroids, may potentiate the development of several problems in RT pts: obesity, hyperglycemia, hyperlipidemia, and hypertension,1 which are not only risk factors for cardiovascular disease but also for graft loss.2,3 We performed a retrospective analysis of all RTs performed at our unit that reached 10 years (y) with a functioning graft. The aim of the study was to evaluate long-term complications and, in view of the results, to seek a possible strategy that minimizes these problems.
- End-Stage Renal Disease in Familial Amyloidosis ATTR Val30Met: APublication . Lobato, L.; Ventura, A.; Beirão, I.; Miranda, H.P.; Seca, R.; Henriques, A.C.; Teixeira, M.; Sarmento, A.M.; Pereira, M.C.Transplant Proc. 2003 May;35(3):1116-20. End-stage renal disease in familial amyloidosis ATTR Val30Met: a definitive indication to combined liver-kidney transplantation. Lobato L, Ventura A, Beirão I, Miranda HP, Seca R, Henriques AC, Teixeira M, Sarmento AM, Pereira MC. Department of Nephrology, and Liver Transplantation Program, Hospital Geral de Santo António, Largo Professor Abel Salazar, 4050, Porto, Portugal. llobato@nctcabo.pt PMID: 12947881 [PubMed - indexed for MEDLINE]